# Virtual Lab Agent

**ID:** `biomedical.protein_science.virtual_lab`
**Version:** 1.0.0
**Status:** Production
**Category:** Protein Science / Multi-Agent Systems

---

## Overview

The **Virtual Lab Agent** is an AI-human collaborative research system that performs sophisticated, interdisciplinary protein science research. It consists of an LLM Principal Investigator agent that guides a team of specialized LLM scientist agents through research meetings, with human researchers providing high-level feedback.

This architecture was validated in Nature 2025, where it successfully designed 92 novel SARS-CoV-2 nanobodies with experimental confirmation of binding activity. The system demonstrates that multi-agent AI collaboration can accelerate scientific discovery by orders of magnitude.

---

## Key Capabilities

### 1. Multi-Agent Research Orchestration

| Agent Role | Responsibility | Tools |
|------------|---------------|-------|
| **Principal Investigator** | Research direction, hypothesis prioritization | Literature synthesis, experimental planning |
| **Computational Biologist** | Structure prediction, molecular simulation | AlphaFold, ESM, Rosetta |
| **Protein Engineer** | Sequence design, mutagenesis strategy | ESM3, ProteinMPNN |
| **Experimentalist** | Protocol generation, validation planning | Lab automation APIs |

### 2. Integrated Computational Pipeline

- **ESM protein language models:** Sequence embedding and fitness prediction
- **AlphaFold-Multimer:** Protein-protein complex structure prediction
- **Rosetta:** Energy minimization and binding affinity estimation
- **Molecular dynamics:** Stability and dynamics assessment

### 3. Nanobody/Antibody Design

- De novo nanobody generation against target antigens
- CDR loop optimization for binding affinity
- Humanization assessment for therapeutic development
- Cross-reactivity prediction across variants

### 4. Research Meeting Simulation

- Automated agenda generation based on research goals
- Agent discussion with hypothesis refinement
- Consensus building and decision documentation
- Human checkpoint for strategic guidance

---

## Usage

### Example Prompt

```text
Design nanobodies targeting the SARS-CoV-2 Omicron XBB.1.5 spike protein RBD.
Use ESM for sequence generation, AlphaFold-Multimer for structure prediction,
and Rosetta for binding energy calculations.

Generate 10 candidate sequences ranked by predicted binding affinity.
Include humanization scores for therapeutic potential.
```

### Expected Output

```
## Virtual Lab Research Session: SARS-CoV-2 Nanobody Design

### Research Meeting #1: Target Analysis
**PI Agent:** The RBD of XBB.1.5 shows mutations at positions 346, 444, 445,
and 460 compared to ancestral strain. We should focus CDR3 contacts away
from hypervariable regions.

**Computational Biologist:** AlphaFold-Multimer predicts stable complex with
Class 1 antibody epitope. Recommend targeting conserved ACE2-binding interface.

### Candidate Nanobodies

| Rank | ID | CDR3 Sequence | Binding Energy (REU) | pLDDT | Humanization |
|------|-----|---------------|---------------------|-------|--------------|
| 1 | VHH-XBB-01 | AAGYSTRAPYDY | -42.3 | 89.2 | 78% |
| 2 | VHH-XBB-02 | AADYRGTAPWDY | -39.8 | 91.4 | 82% |
| 3 | VHH-XBB-03 | ASGFRTRAPVDY | -38.1 | 87.6 | 75% |
...

### Recommendation
Top 3 candidates recommended for experimental validation via SPR and
pseudovirus neutralization assay.
```

### LLM Agent Integration

```python
@tool
def run_virtual_lab_session(
    research_goal: str,
    target_protein: str,
    num_candidates: int = 10,
    include_experimental_protocol: bool = True
) -> str:
    """
    Initiates a Virtual Lab research session for protein design.

    Args:
        research_goal: High-level research objective
        target_protein: UniProt ID or PDB ID of target
        num_candidates: Number of designs to generate
        include_experimental_protocol: Generate validation protocols

    Returns:
        Research session transcript with ranked candidates
    """
    pass
```

---

## Prerequisites

### Required APIs/Models

| Resource | Purpose | Access |
|----------|---------|--------|
| **ESM-2/ESM3** | Protein language model | HuggingFace / EvolutionaryScale |
| **AlphaFold-Multimer** | Complex structure prediction | ColabFold API or local |
| **Rosetta** | Energy calculations | Academic license |
| **PDB** | Reference structures | Public API |

### Dependencies

```
torch>=2.0
transformers>=4.30
biotite>=0.37
pyrosetta>=2023.0  # Academic license required
openmm>=8.0
```

---

## Methodology

### Multi-Agent Architecture

```
Human Researcher (Strategic Oversight)
        ↓
Principal Investigator Agent
    ├── Literature Review Agent
    ├── Computational Biology Agent
    │       ├── ESM Analysis
    │       ├── AlphaFold Prediction
    │       └── Rosetta Scoring
    ├── Protein Engineering Agent
    │       ├── Sequence Generation
    │       └── Mutagenesis Planning
    └── Experimental Design Agent
            ├── Protocol Generation
            └── Validation Planning
```

### Design Pipeline

1. **Target analysis:** Identify binding epitopes and conserved regions
2. **Scaffold selection:** Choose nanobody framework (VHH)
3. **CDR generation:** ESM-guided sequence design
4. **Structure prediction:** AlphaFold-Multimer complex modeling
5. **Energy scoring:** Rosetta binding energy estimation
6. **Diversity filtering:** Ensure sequence diversity in candidates
7. **Humanization:** Assess immunogenicity risk

---

## Related Skills

- **ESM3 Protein Design Agent:** Core sequence generation engine
- **AlphaFold3 Agent:** Structure prediction capabilities
- **Antibody Design (MAGE):** Complementary antibody design approaches

---

## References

- **Swanson et al. (2025):** "The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation." *Nature*
- [Virtual Lab GitHub](https://github.com/zou-group/virtual-lab)
- EvolutionaryScale ESM documentation

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu
